{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:17:42Z","timestamp":1790641062143,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802718"],"award-info":[{"award-number":["81802718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1504817"],"award-info":[{"award-number":["U1504817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670088"],"award-info":[{"award-number":["81670088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Science & Technology Department of Henan Province","award":["182102310335"],"award-info":[{"award-number":["182102310335"]}]},{"name":"Foundation of Science & Technology Department of Henan Province","award":["162102410009"],"award-info":[{"award-number":["162102410009"]}]},{"name":"Foundation of Science & Technology Department of Henan Province","award":["172102410019"],"award-info":[{"award-number":["172102410019"]}]},{"name":"Science Foundation of Kaifeng City","award":["1608004"],"award-info":[{"award-number":["1608004"]}]},{"name":"Science Foundation of Kaifeng City","award":["1703016"],"award-info":[{"award-number":["1703016"]}]},{"name":"Science Foundation of Henan University","award":["yqpy20170044"],"award-info":[{"award-number":["yqpy20170044"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.canlet.2019.04.031","type":"journal-article","created":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T18:10:40Z","timestamp":1556475040000},"page":"60-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K\/AKT\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways"],"prefix":"10.1016","volume":"455","author":[{"given":"Qian","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Guo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-8437","authenticated-orcid":false,"given":"Dong-Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ying","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Feng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.04.031_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrclinonc.2017.74","article-title":"Clinical utility of gene-expression signatures in early stage breast cancer","volume":"14","author":"Kwa","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.04.031_bib2","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","article-title":"Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls","volume":"9","author":"Momozawa","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.04.031_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.04.031_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007802","article-title":"A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability","volume":"14","author":"Jadaliha","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2019.04.031_bib5","doi-asserted-by":"crossref","first-page":"5896786","DOI":"10.1155\/2018\/5896786","article-title":"New insights into the role of exercise in inhibiting mTOR signaling in triple-negative breast cancer","volume":"2018","author":"Agostini","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.canlet.2019.04.031_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/bjc.2016.400","article-title":"Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk","volume":"116","author":"Cook","year":"2017","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2019.04.031_bib7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1021\/acs.biomac.7b00208","article-title":"CXCR4-Targeted and redox responsive dextrin nanogel for metastatic breast cancer therapy","volume":"18","author":"Zhang","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.canlet.2019.04.031_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biomaterials.2015.02.002","article-title":"Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models","volume":"51","author":"Li","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2019.04.031_bib9","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1021\/acsnano.8b05189","article-title":"Breast cancer chemo-immunotherapy through liposomal delivery of an immunogenic cell death stimulus plus interference in the Ido-1 pathway","volume":"12","author":"Lu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2019.04.031_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2019.04.031_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/physrev.00017.2011","article-title":"Physiological implications of hydrogen sulfide: a whiff exploration that blossomed","volume":"92","author":"Wang","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2019.04.031_bib12","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1039\/C6CS00212A","article-title":"A practical guide to working with H2S at the interface of chemistry and biology","volume":"45","author":"Hartle","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.canlet.2019.04.031_bib13","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-\u03b2-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2019.04.031_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2019.04.031_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrm3391","article-title":"H\u2082S signalling through protein sulfhydration and beyond","volume":"13","author":"Paul","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2019.04.031_bib16","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ncomms2371","article-title":"A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells","volume":"4","author":"Shibuya","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.04.031_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bcp.2017.11.014","article-title":"A review of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic applications","volume":"149","author":"Powell","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.031_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.addr.2015.11.011","article-title":"Hyaluronic acid for anticancer drug and nucleic acid delivery","volume":"97","author":"Dosio","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2019.04.031_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/nn405383a","article-title":"Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer","volume":"8","author":"Jung","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2019.04.031_bib20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nmat4048","article-title":"Enhanced lubrication on tissue and biomaterial surfaces through peptide-mediated binding of hyaluronic acid","volume":"13","author":"Singh","year":"2014","journal-title":"Nat. Mater."},{"key":"10.1016\/j.canlet.2019.04.031_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.biomaterials.2018.05.037","article-title":"Assessment of in vivo degradation profiles of hyaluronic acid hydrogels using temporal evolution of chemical exchange saturation transfer (CEST) MRI","volume":"178","author":"Shazeeb","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2019.04.031_bib22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/bc500150s","article-title":"Design and synthesis of polymeric hydrogen sulfide donors","volume":"25","author":"Hasegawa","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.canlet.2019.04.031_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.38","article-title":"The zinc-finger transcriptional factor Slug transcriptionally downregulates ER\u03b1 by recruiting lysine-specific demethylase 1 in human breast cancer","volume":"6","author":"Bai","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2019.04.031_bib24","doi-asserted-by":"crossref","first-page":"9647809","DOI":"10.1155\/2018\/9647809","article-title":"Hydrogen sulfide alleviates lipopolysaccharide-induced diaphragm dysfunction in rats by reducing apoptosis and inflammation through ROS\/MAPK and TLR4\/NF-\u03baB signaling pathways","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.canlet.2019.04.031_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12885-018-4391-9","article-title":"PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K\/AKT\/mTOR signaling pathways","volume":"18","author":"Wu","year":"2018","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2019.04.031_bib26","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1158\/0008-5472.CAN-13-2923","article-title":"CDK4\/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancers","volume":"74","author":"Heilmann","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.04.031_bib27","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/cncr.29957","article-title":"Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma","volume":"122","author":"Ellingson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2019.04.031_bib28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.peptides.2010.01.007","article-title":"Anti-tumor effects of a novel chimeric peptide on S180 and H22 xenografts bearing nude mice","volume":"31","author":"Wu","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.canlet.2019.04.031_bib29","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/bcr2834","article-title":"Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis","volume":"13","author":"Keam","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2019.04.031_bib30","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1158\/0008-5472.CAN-14-1408","article-title":"Host deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis","volume":"74","author":"Liu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.04.031_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2011.02.041","article-title":"Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf","volume":"306","author":"Pitchakarn","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.04.031_bib32","doi-asserted-by":"crossref","first-page":"35468","DOI":"10.1038\/srep35468","article-title":"Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4\/DR5 expression in a p53-dependent manner","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.04.031_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2019.04.031_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","article-title":"Targeting the PI3K pathway in cancer: are we making headway?","volume":"15","author":"Janku","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.04.031_bib35","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41467-017-02287-5","article-title":"Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality","volume":"8","author":"Kitagawa","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.04.031_bib36","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2019.04.031_bib37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/gutjnl-2016-312986","article-title":"Apicobasal polarity and Ras\/Raf\/MEK\/ERK signalling in cancer","volume":"66","author":"Peng","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2019.04.031_bib38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/2159-8290.CD-16-0647","article-title":"The APC\/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function","volume":"7","author":"Wan","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2019.04.031_bib39","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2014.05.045","article-title":"The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy","volume":"158","author":"Scherz-Shouval","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.04.031_bib40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nbt.3506","article-title":"An injectable nanoparticle generator enhances delivery of cancer therapeutics","volume":"34","author":"Xu","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2019.04.031_bib41","first-page":"212","article-title":"Improving the outcome for children with cancer: development of targeted new agents","volume":"65","author":"Adamson","year":"2015","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.canlet.2019.04.031_bib42","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S1470-2045(14)71133-7","article-title":"Nail toxicities induced by systemic anticancer treatments","volume":"16","author":"Robert","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2019.04.031_bib43","doi-asserted-by":"crossref","first-page":"12541","DOI":"10.1021\/jacs.6b06937","article-title":"Chemical approach to positional isomers of glucose-platinum conjugates reveals specific cancer targeting through glucose-transporter-mediated uptake in vitro and in vivo","volume":"138","author":"Patra","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.canlet.2019.04.031_bib44","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1039\/c3sc22205e","article-title":"Glucose conjugation for the specific targeting and treatment of cancer","volume":"4","author":"Calvaresi","year":"2013","journal-title":"Chem. Sci."},{"key":"10.1016\/j.canlet.2019.04.031_bib45","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1021\/acs.bioconjchem.6b00332","article-title":"Targeting iron in colon cancer via glycoconjugation of thiosemicarbazone prochelators","volume":"27","author":"Akam","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.canlet.2019.04.031_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2015.08.004","article-title":"Hydrogen sulfide in cancer: friend or foe?","volume":"50","author":"Wu","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.canlet.2019.04.031_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2014.05.002","article-title":"Peptide-based cancer therapy: opportunity and challenge","volume":"351","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.04.031_bib48","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1073\/pnas.1524668113","article-title":"Augmented efficacy of brentuximab vedotin combined with ruxolitinib and\/or Navitoclax in a murine model of human Hodgkin's lymphoma","volume":"113","author":"Ju","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2019.04.031_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2016.10.019","article-title":"ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo","volume":"114","author":"De Cicco","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2019.04.031_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2013.10","article-title":"Development of PI3K inhibitors: lessons learned from early clinical trials","volume":"10","author":"Rodon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.04.031_bib51","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2559.2011.03856.x","article-title":"Activation of the PI3K\/Akt\/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder","volume":"58","author":"Sun","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2019.04.031_bib52","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/onc.2015.329","article-title":"Stamping out RAF and MEK1\/2 to inhibit the ERK1\/2 pathway: an emerging threat to anticancer therapy","volume":"35","author":"Mandal","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.04.031_bib53","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12885-016-2767-2","article-title":"Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K\/AKT and Ras\/Raf\/MEK\/ERK pathways","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2019.04.031_bib54","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1158\/1078-0432.CCR-11-2381","article-title":"The clinical effect of the dual-targeting strategy involving PI3K\/AKT\/mTOR and RAS\/MEK\/ERK pathways in patients with advanced cancer","volume":"18","author":"Shimizu","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.04.031_bib55","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/1471-2407-12-612","article-title":"Alternative dosing of dual PI3K and MEK inhibition in cancer therapy","volume":"12","author":"Jokinen","year":"2012","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2019.04.031_bib56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ctrv.2013.03.009","article-title":"Targeting the PI3K\/AKT\/mTOR and Raf\/MEK\/ERK pathways in the treatment of breast cancer","volume":"39","author":"Saini","year":"2013","journal-title":"Cancer Treat Rev."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351930268X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351930268X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:43:22Z","timestamp":1759592602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438351930268X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":56,"alternative-id":["S030438351930268X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.04.031","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K\/AKT\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}